Profile data is unavailable for this security.
About the company
biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
- Revenue in USD (TTM)187.23m
- Net income in USD6.87m
- Incorporated2020
- Employees194.00
- LocationBiote Corp1875 W. Walnut Hill Ln #100, Floor 5IRVING 75038United StatesUSA
- Phone+1 (972) 486-9346
- Fax+1 (916) 443-1908
- Websitehttps://haymakeracquisition.com/
Mergers & acquisitions
| Acquired company | BTMD:NMQ since announced | Transaction value |
|---|---|---|
| FH Investments Inc | 30.37% | 9.00m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chegg Inc | 683.34m | -626.92m | 190.75m | 1.90k | -- | 0.5203 | -- | 0.2792 | -6.12 | -6.12 | 5.83 | 3.54 | 0.4433 | -- | 32.83 | 359,084.60 | -40.67 | 2.58 | -51.08 | 2.77 | 68.03 | 70.64 | -91.74 | 8.07 | -- | -- | 0.6218 | 0.00 | -6.60 | 17.41 | -93.18 | -- | 21.61 | -- |
| Goodheart-Willcox Company Inc | -100.00bn | -100.00bn | 251.55m | 56.00 | -- | 6.95 | -- | -- | -- | -- | -- | 61.89 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | 21.66 | -- | 78.03 | -- | -- | -- |
| biote Corp | 187.23m | 6.87m | 331.27m | 194.00 | 27.95 | -- | 17.68 | 1.77 | 0.2186 | 0.2186 | 5.64 | -4.62 | 1.61 | 4.27 | 23.35 | 965,118.60 | 13.31 | -- | 16.33 | -- | 69.65 | -- | 8.24 | -- | 0.9198 | 5.45 | 4.13 | -- | 12.37 | -- | 442.21 | -- | -- | -- |
| Value Line, Inc. | 36.63m | 20.04m | 432.10m | 122.00 | 21.57 | 4.60 | 20.19 | 11.80 | 2.13 | 2.13 | 3.89 | 9.97 | 0.2705 | -- | 26.79 | 300,229.50 | 14.80 | 16.40 | 17.87 | 20.70 | 84.85 | 86.87 | 54.72 | 49.97 | -- | -- | 0.00 | 45.52 | -5.56 | 0.6695 | 5.24 | 9.63 | -8.79 | 8.06 |
| Daily Journal Corporation | 71.61m | 44.90m | 705.92m | 350.00 | 15.72 | 2.80 | 15.63 | 9.86 | 32.61 | 32.61 | 52.00 | 182.90 | 0.1946 | 164.33 | 3.64 | 204,594.30 | 12.20 | 2.53 | 13.71 | 2.83 | 89.44 | 90.83 | 62.70 | 13.92 | 8.58 | -- | 0.1022 | 0.00 | 25.37 | 10.71 | 128.37 | -- | -16.51 | -- |
| Gannett Co Inc | 2.60bn | -96.48m | 828.03m | 12.80k | -- | 3.32 | 13.99 | 0.3187 | -0.6902 | -0.6902 | 15.66 | 1.69 | 1.19 | 62.83 | 10.56 | 202,959.10 | -4.43 | -7.31 | -5.89 | -9.39 | 37.27 | 39.19 | -3.72 | -7.35 | 0.7498 | 0.7856 | 0.8028 | -- | -9.57 | 11.78 | 64.37 | -- | 26.78 | -- |
| Scholastic Corp | 1.59bn | 12.10m | 904.79m | 4.77k | 100.80 | 0.8866 | 9.24 | 0.5692 | 0.3176 | 0.3176 | 51.28 | 36.10 | 0.8987 | 2.36 | 6.20 | 333,270.40 | 0.684 | 1.30 | 1.01 | 1.88 | 55.65 | 52.43 | 0.7612 | 1.62 | 0.7718 | -- | 0.0118 | 91.30 | -6.71 | -0.7887 | -85.98 | -4.95 | -9.41 | 5.92 |
| Cengage Learning Holdings II Inc | 1.50bn | -80.90m | 1.26bn | 4.40k | -- | -- | 9.75 | 0.8353 | -1.30 | -1.30 | 24.05 | 1.84 | 0.5728 | 10.49 | 7.45 | 341,522.70 | -3.08 | -8.41 | -4.22 | -10.83 | 52.83 | 50.59 | -5.38 | -17.26 | 0.7547 | 0.8423 | 0.9336 | -- | 5.56 | 0.9882 | -101.24 | -- | -4.80 | -- |
| Holder | Shares | % Held |
|---|---|---|
| 325 Capital LLCas of 30 Jun 2024 | 3.77m | 11.56% |
| Roystone Capital Management LPas of 31 Dec 2023 | 3.07m | 9.43% |
| Bandera Partners LLCas of 30 Jun 2024 | 2.44m | 7.48% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 1.45m | 4.44% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 1.33m | 4.07% |
| Wasatch Advisors LPas of 30 Jun 2024 | 1.29m | 3.94% |
| Kanen Wealth Management LLCas of 30 Jun 2024 | 1.15m | 3.53% |
| Boston Partners Global Investors, Inc.as of 30 Jun 2024 | 669.73k | 2.06% |
| Dimensional Fund Advisors LPas of 30 Jun 2024 | 636.14k | 1.95% |
| Geode Capital Management LLCas of 30 Jun 2024 | 618.21k | 1.90% |
